Last reviewed · How we verify
Malignant tumor of fallopian tube
Approved treatments
- Avastin · Washington University School of Medicine
- Bevacizumab · Roche
Bevacizumab binds VEGF and prevents interaction with endothelial cell receptors Flt-1 and KDR. - Avastin · Roche
Bevacizumab works by binding to VEGF-A, preventing it from promoting the growth of new blood vessels that feed tumors.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Malignant tumor of fallopian tube patent landscape — cliff calendar, originator estates, attackable patents
- Malignant tumor of fallopian tube treatment landscape brief
- Malignant tumor of fallopian tube treatment updates RSS
Frequently asked questions about Malignant tumor of fallopian tube
What drugs treat Malignant tumor of fallopian tube?
Tracked treatments include Avastin, Bevacizumab.
What is the treatment for Malignant tumor of fallopian tube?
Standard treatment for Malignant tumor of fallopian tube includes Avastin, Bevacizumab. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Malignant tumor of fallopian tube patent cliff · Malignant tumor of fallopian tube CI report
- Treatment: Avastin · Washington University School of Medicine
- Treatment: Bevacizumab · Roche
- Treatment: Avastin · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing